News

Outset Medical to Present at RBC Global Healthcare Conference

SAN JOSE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering…

8 months ago

SRx Health Solutions Purchases $1.5 Million of Solana Tokens as Part of its Asset Allocation Diversification Strategy

TAMPA, Fla., May 09, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global…

8 months ago

Best Bodybuilding Supplements: Top Legal Steroids & Supplements For Bodybuilding & Muscle Growth

Backed by Wolfson Brands (UK) Limited, discover proven bodybuilding supplements & legal steroids that actually work. Build lean muscle, burn…

8 months ago

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Conduit secures a composition of matter patent from the Korean Intellectual Property Office for its lead asset, AZD1656, a Glucokinase…

8 months ago

Ocugen Provides Business Update with First Quarter 2025 Financial Results

Conference Call and Webcast Today at 8:30 a.m. ET OCU400 Phase 3 clinical trial for retinitis pigmentosa (RP) is progressing…

8 months ago

Garuda Therapeutics Announces Name Change to Stratus Therapeutics to Reflect Mission of Pioneering Full Hematopoietic System Renewal

New corporate identity reflects the continued evolution toward developing the Stratus Prime™ platform to deliver on-demand, Prime HSCs™ and Prime…

8 months ago

Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025

DURHAM, N.C., May 09, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable,…

8 months ago

PMV Pharmaceuticals Reports First Quarter 2025 Financial Results and Corporate Highlights

Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53…

8 months ago

BlossomHill Therapeutics Appoints Jason Keyes as Chief Financial Officer and Executive Vice President

Jason Keyes is a veteran corporate executive within the biopharmaceutical industry who brings a breadth of leadership experience in the…

8 months ago

Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada  

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced…

8 months ago